Elan Canine Flu Vaccine Receives USDA Approval

Elanco’s New Vaccine Offers Broad protection Against Canine flu

Indianapolis, IN – In a important step forward for canine respiratory health, Elanco Animal Health announced today that its bivalent canine flu vaccine, Trucan Ultra CIV, has received approval from teh U.S. Department of Agriculture (USDA). This new vaccine is designed to protect dogs against both the H3N2 and H3N8 strains of canine influenza virus, offering a more comprehensive defense than currently available options.

Shares of Elanco rose 1.5% to $14.75 in early trading following the announcement, signaling investor confidence in the product’s potential.

Understanding Canine Flu

Canine influenza, caused by influenza A virus, is a highly contagious respiratory disease in dogs. The virus spreads easily through respiratory droplets produced when infected dogs cough, sneeze, or bark. Certain dogs are at higher risk, including those who frequently socialize, have pre-existing respiratory conditions, or haven’t been fully vaccinated.

Trucan Ultra CIV: A Dual-Strain defense

Currently, Merck’s Nobivac NXT vaccine protects against the H3N2 strain, but Trucan Ultra CIV distinguishes itself by providing protection against both prevalent strains in the united States. Elanco’s research demonstrates the vaccine’s effectiveness in protecting lung health and alleviating clinical symptoms, including reducing viral shedding.

Key Findings from Vaccine Trials

Studies conducted by Elanco revealed that the vaccine not only improved clinical signs but also prevented the progress of abnormal spots on the lungs of vaccinated dogs infected with the H3N2 strain – a finding not observed with existing vaccines.Furthermore, the vaccine was shown to be safe across a diverse range of breeds and ages in field safety trials.

“This approval represents a major advancement in our ability to protect dogs from the serious health risks associated with canine influenza,” a spokesperson for Elanco stated. “Trucan Ultra CIV offers a broader spectrum of protection,giving pet owners greater peace of mind.”

Veterinarians are expected to begin offering Trucan Ultra CIV in the coming weeks. Pet owners are encouraged to consult with their veterinarian to determine if this vaccine is appropriate for their dog’s individual needs and risk factors.

What specific data supported the expanded data set resulting from the USDA’s full approval of the Elan canine influenza vaccine?

What Does USDA Approval Mean for the Elan Canine Influenza Vaccine?

On July 9,2025,Elan Animal Health announced a significant milestone: full USDA (United States Department of Agriculture) approval for its canine influenza vaccine. This isn’t just another pet vaccine; it represents a leap forward in protecting dogs against the highly contagious canine influenza virus (CIV). Previously available under conditional approval,this full licensure signifies rigorous testing and proven efficacy,offering peace of mind to pet owners and veterinarians alike. This approval covers both strains of CIV currently circulating: H3N8 and H3N2.

Understanding Canine Influenza: Symptoms and Transmission

Canine influenza, often called “dog flu,” is a respiratory disease caused by influenza A viruses. It’s highly contagious,spreading easily between dogs in close contact. Key symptoms to watch for include:

Coughing: Often a persistent, moist cough.

Fever: Elevated body temperature.

Nasal Discharge: Clear or mucopurulent discharge from the nose.

Lethargy: Reduced energy levels and general weakness.

Loss of Appetite: Decreased interest in food.

Pneumonia: In severe cases, canine influenza can lead to pneumonia.

Transmission occurs through:

Direct contact: Nose-to-nose contact with infected dogs.

Aerosol Transmission: Inhaling airborne droplets produced by coughing or sneezing.

Fomites: Contaminated objects like water bowls, leashes, and toys. The virus can survive on surfaces for a limited time.

The Elan Vaccine: How it Works & What’s New

The Elan canine flu vaccine is an inactivated virus vaccine, meaning it contains killed virus particles. This stimulates the dog’s immune system to produce antibodies without causing the disease itself. The USDA approval process involved extensive trials demonstrating the vaccine’s safety and ability to significantly reduce the severity and duration of illness if a vaccinated dog does contract canine influenza.

Key improvements with the full approval include:

Expanded Data Set: More comprehensive data on long-term efficacy and safety.

Increased Confidence: Veterinarians can prescribe with greater assurance.

Wider Availability: full approval frequently enough leads to broader distribution channels.

Strain coverage: Protection against both prevalent H3N8 and H3N2 strains.

Vaccination Schedule & Who Should Get Vaccinated?

The Elan canine flu vaccine typically requires a series of two initial doses, administered 2-4 weeks apart. Annual boosters are then recommended to maintain optimal immunity.

Consider vaccination for:

Dogs that frequent boarding kennels or doggy daycare: These environments are high-risk due to the close proximity of many dogs.

Dogs that participate in dog shows or other group activities: Similar to boarding facilities, these events increase exposure.

Dogs that travel frequently: Exposure risk increases with travel, especially by air.

Puppies: Starting the vaccination series as early as 6-8 weeks of age is recommended.

Dogs with underlying health conditions: Canine influenza can be more severe in dogs with compromised immune systems.

Consult with your veterinarian to determine the best vaccination schedule for your dog based on their individual risk factors and lifestyle.

Potential Side Effects & What to Expect

Like all vaccines, the Elan canine flu vaccine can cause mild side effects.These are typically short-lived and include:

Lethargy: Temporary tiredness.

Mild Fever: A slight increase in body temperature.

Soreness at the Injection Site: Tenderness or swelling where the vaccine was administered.

decreased Appetite: Temporary loss of interest in food.

Serious adverse reactions are rare. If you notice any concerning symptoms after vaccination, such as facial swelling, difficulty breathing, or persistent vomiting, contact your veterinarian immediatly.

Cost of the Elan Canine Flu Vaccine

the cost of the canine influenza vaccine varies depending on your location and veterinarian. Expect to pay between $50 and $100 for the initial series (two doses), and around $30-$60 for annual boosters.Many veterinary clinics offer package deals that include other core vaccines, possibly reducing the overall cost. Pet insurance may cover the cost of vaccinations; check your policy details.

Real-World Impact: Case Studies & Outbreak Prevention

In 2018, a significant outbreak of canine influenza occurred in several states, highlighting the importance of vaccination. Veterinary hospitals reported a surge in cases,overwhelming resources and causing significant distress for pet owners. Clinics that had proactively encouraged vaccination among their clients experienced significantly fewer cases compared to those where vaccination rates were lower. This real-world example underscores the vaccine’s effectiveness in mitigating the spread of the virus and protecting canine populations.Ongoing surveillance and reporting of CIV cases are crucial for tracking the virus’s evolution and ensuring the vaccine remains effective.

Resources for Further Information

American Veterinary Medical Association (AVMA): https://www.avma.org/

Centers for Disease Control and Prevention (CDC) – Canine Influenza: [https://www.cdc.gov/flu/canine-flu/index.htm](